Human trials of experimental AIDS vaccines: recombinant envelope proteins.
作者信息
Snart R S
机构信息
Département de Physiologie Cellulaire, Université Pierre et Marie Curie, Paris, France.
出版信息
AIDS. 1988;2 Suppl 1:S107-11. doi: 10.1097/00002030-198800001-00016.
Abstract
摘要
相似文献
1
Human trials of experimental AIDS vaccines: recombinant envelope proteins.实验性艾滋病疫苗的人体试验：重组包膜蛋白
AIDS. 1988;2 Suppl 1:S107-11. doi: 10.1097/00002030-198800001-00016.
2
Vaccines and immunology. Overview.疫苗与免疫学。概述。
AIDS. 1988;2 Suppl 1:S91-4.
3
Human trials of AIDS vaccines: novel means of passive and active immunotherapy.艾滋病疫苗的人体试验：被动和主动免疫疗法的新手段。
AIDS. 1988;2 Suppl 1:S129-31.
4
Antigenic structures recognized by T cells: towards the rational design of an AIDS vaccine.
AIDS. 1988;2 Suppl 1:S95-101.
5
Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts.被感染和免疫宿主识别的HIV-1包膜免疫显性B细胞表位。
AIDS. 1988;2 Suppl 1:S41-5. doi: 10.1097/00002030-198800001-00006.
6
Part of AIDS virus is patented.
Science. 1988 Feb 26;239(4843):970. doi: 10.1126/science.2830668.
7
Patterns of antigenaemia and antibody response in patients infected with human immunodeficiency virus (HIV) according to clinical state.根据临床状态，人类免疫缺陷病毒（HIV）感染患者的抗原血症和抗体反应模式。
J Clin Pathol. 1989 Mar;42(3):282-3. doi: 10.1136/jcp.42.3.282.
8
Harming and protecting responses to HIV.对艾滋病毒的伤害性和保护性反应。
Res Immunol. 1989 Jan;140(1):99-103; discussion 123-4. doi: 10.1016/0923-2494(89)90012-6.
9
AIDS vaccines inch closer to useful existence.艾滋病疫苗离实际可用又近了一步。
JAMA. 1991 Mar 20;265(11):1356-7.
10
Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.HIV gp120与gp120特异性抗体在阻断人类T细胞活化方面的协同作用。
Science. 1989 Sep 22;245(4924):1380-2. doi: 10.1126/science.2571187.
Zotero 插件